675 related articles for article (PubMed ID: 20551304)
1. Fecal MicroRNAs as novel biomarkers for colon cancer screening.
Link A; Balaguer F; Shen Y; Nagasaka T; Lozano JJ; Boland CR; Goel A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1766-74. PubMed ID: 20551304
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
3. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer.
Link A; Becker V; Goel A; Wex T; Malfertheiner P
PLoS One; 2012; 7(8):e42933. PubMed ID: 22905187
[TBL] [Abstract][Full Text] [Related]
6. Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians.
Phua LC; Chue XP; Koh PK; Cheah PY; Chan EC; Ho HK
Oncol Rep; 2014 Jul; 32(1):97-104. PubMed ID: 24841830
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening.
Kunte DP; DelaCruz M; Wali RK; Menon A; Du H; Stypula Y; Patel A; Backman V; Roy HK
PLoS One; 2012; 7(9):e45591. PubMed ID: 23049818
[TBL] [Abstract][Full Text] [Related]
8. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study.
Pardini B; Ferrero G; Tarallo S; Gallo G; Francavilla A; Licheri N; Trompetto M; Clerico G; Senore C; Peyre S; Vymetalkova V; Vodickova L; Liska V; Vycital O; Levy M; Macinga P; Hucl T; Budinska E; Vodicka P; Cordero F; Naccarati A
Gastroenterology; 2023 Sep; 165(3):582-599.e8. PubMed ID: 37263306
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S
Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
11. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.
Yau TO; Wu CW; Dong Y; Tang CM; Ng SS; Chan FK; Sung JJ; Yu J
Br J Cancer; 2014 Oct; 111(9):1765-71. PubMed ID: 25233396
[TBL] [Abstract][Full Text] [Related]
12. miRNA as markers for the diagnostic screening of colon cancer.
Ahmed FE
Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
[TBL] [Abstract][Full Text] [Related]
13. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery.
Rotelli MT; Di Lena M; Cavallini A; Lippolis C; Bonfrate L; Chetta N; Portincasa P; Altomare DF
Int J Colorectal Dis; 2015 Jul; 30(7):891-8. PubMed ID: 25989926
[TBL] [Abstract][Full Text] [Related]
14. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
16. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer.
Kalimutho M; Del Vecchio Blanco G; Di Cecilia S; Sileri P; Cretella M; Pallone F; Federici G; Bernardini S
J Gastroenterol; 2011 Dec; 46(12):1391-402. PubMed ID: 21863218
[TBL] [Abstract][Full Text] [Related]
18. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer.
Li JM; Zhao RH; Li ST; Xie CX; Jiang HH; Ding WJ; Du P; Chen W; Yang M; Cui L
Saudi Med J; 2012 Jan; 33(1):24-9. PubMed ID: 22273643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
